Andrea Wilson Woods is a writer, speaker, and patient advocate dedicated to improving liver cancer outcomes. She is the founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, named after her sister, who died from the disease at age 15. With a background in teaching, storytelling, and nonprofit leadership, she blends compassion with strategic insight to drive change in healthcare. Andrea's mission is to ensure no one faces liver cancer alone, turning personal loss into a powerful force for awareness and action.

Dr. Speliotes is the Keith Henley Endowed Professor of Gastroenterology and Computational Medicine and Bioinformatics at the University of Michigan. She is an internationally leader in the genetics of human obesity, MASLD, and cardiometabolic disease having identified thousands of genetic variants that cause these diseases. She developed bioinformatic methods to identify causal tissues, genes and pathways highlighted by genomic analyses.

Chris Burns is an Emmy Award-winning cinematographer, filmmaker, and founder of Ayumi Creative, where he has spent more than two decades creating cinematic stories for Netflix, HBO Max, A&E, Discovery, national brands, and nonprofit organizations. His work is rooted in authentic human storytelling and the power of visual media to inspire action.

Dr. Adnan Said is a Professor in the Division of Gastroenterology and Hepatology within the Department of Medicine at the University of Wisconsin (UW) School of Medicine and Public Health in Madison, WI. He also serves as program director of the UW Health Transplant hepatology Fellowship, Director of the UW Health Metabolic Liver Clinic and as Medical Director of the VA Liver Transplant Program.Dr.

Professor of Medicine, University of Washington, Director of Hepatology, Veterans Affairs Puget Sound Health Care System.
My areas of interest include liver cancer screening and risk stratification, clinical epidemiology of chronic liver disease, cirrhosis, and HCC, prediction modeling, target trial emulation and the role of cholesterol in MASLD.

Dr. Sharon H. Jaycox, PhD, MHA
Dr. Sharon H. Jaycox is a strategic healthcare and patient advocacy executive with more than 12 years of experience advancing patient-centered research, clinical development integration, health equity, and community engagement across public health, liver disease, metabolic health, and clinical research environments.

Kerry Sivia is a patient advocate living with metabolic dysfunction–associated steatotic liver disease (MASLD/MASH), autoimmune hepatitis, primary biliary cholangitis (PBC), and cirrhosis. Since receiving her diagnoses in 2021, she has become a leading voice for patient-centered advocacy in hepatology care, focusing on multidisciplinary collaboration, health equity, and the lived experience of people affected by liver disease.

Allysa Saggese is a graduate of Columbia University School of Nursing and is an ANCC Board Certified Adult Gerontology Primary Care Nurse Practitioner currently specializing in hepatology and research at Weill Cornell Medicine in New York City.

Whitney Steinmetz is a board-certified family nurse practitioner who provides patient-focused, evidence-based care in gastroenterology and hepatology. She has a passion for improving access to care in rural healthcare environments. Dr. Steinmetz earned her bachelor's of science degree with honors, Magna Cum Laude, at the University of Arizona.

I am a gastroenterologist and hepatologist at Yale School of Medicine with a research focus on decision science in liver cancer screening and gene-environment interactions that influence liver cancer risk.